Literature DB >> 19282356

Day 5 morning serum cortisol predicts hypothalamic-pituitary-adrenal function after transsphenoidal surgery for pituitary tumors.

Channa N Jayasena1, Kunal A Gadhvi, Bhavini Gohel, Niamh M Martin, Nigel Mendoza, Karim Meeran, Waljit S Dhillo.   

Abstract

BACKGROUND: Adrenal insufficiency is a complication of transsphenoidal surgery (TSS) for pituitary adenoma, and correct identification of patients requiring glucocorticoid replacement is important. Controversy exists over which early postoperative 9 AM cortisol concentration reliably predicts hypothalamic-pituitary-adrenal (HPA) axis reserve, as defined by the insulin tolerance test (ITT).
METHODS: Data were reviewed for 36 patients undergoing TSS followed by day 5 postoperative 9 AM cortisol measurement and ITT 6 weeks postsurgery. All patients received postoperative glucocorticoid replacement, which was discontinued if the 9 AM serum cortisol was >300 nmol/L.
RESULTS: Of 23 patients who failed the ITT (peak cortisol <500 nmol/L), 20 also had a day 5, 9 AM serum cortisol <300 nmol/L. Nine of 13 patients who passed the ITT had a day 5, 9 AM cortisol >300 nmol/L. The cutoff cortisol concentration of 300 nmol/L had 86.9% (66.4%-97.2%) diagnostic sensitivity, 69.2% (38.6%-90.9%) diagnostic specificity, and 83.3% (61.8%-94.5%) positive predictive value (PPV) for detecting secondary adrenal insufficiency. Increasing the cutoff to 392 nmol/L resulted in 100% (85.2%-100%) sensitivity, 46.1% (19.2%-74.9%) specificity, and 76.6% (57.3%-89.4%) PPV. Decreasing the cutoff to 111 nmol/L resulted in 100% (75.3%-100%) specificity and 100% (67.9%-100%) PPV, although sensitivity was 47.8% (26.8%-69.4%).
CONCLUSIONS: A day 5 post-TSS 9 AM serum cortisol <111 nmol/L reliably detects secondary adrenal insufficiency, and concentrations >392 nmol/L support intact HPA function. Because concentrations of 111-392 nmol/L are poorly predictive of HPA function, glucocorticoid replacement should continue in such cases until definitive testing is performed using an ITT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19282356     DOI: 10.1373/clinchem.2008.117374

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  12 in total

1.  The postoperative cortisol stress response following transsphenoidal pituitary surgery: a potential screening method for assessing preserved pituitary function.

Authors:  Gabriel Zada; Amir Tirosh; Abel P Huang; Edward R Laws; Whitney W Woodmansee
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

2.  Pituitary insufficiency after operation of supratentorial intra- and extraaxial tumors outside of the sellar-parasellar region?

Authors:  Dorothee Wachter; Nicole Gondermann; Matthias F Oertel; Ulf Nestler; Veit Rohde; Dieter-Karsten Böker
Journal:  Neurosurg Rev       Date:  2011-06-15       Impact factor: 3.042

Review 3.  Is peri-operative steroid replacement therapy necessary for the pituitary adenomas treated with surgery? A systematic review and meta analysis.

Authors:  Mamatemin Tohti; Junyang Li; Yuan Zhou; Yuebing Hu; Zhuang Yu; Chiyuan Ma
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

4.  Recovery Room Cortisol Predicts Long-Term Glucocorticoid Need After Transsphenoidal Surgery for Pituitary Tumors.

Authors:  Amro Qaddoura; Tenzin N Shalung; Michael P Meier; Jeannette Goguen; Rowan Jing; Stanley Zhang; Kalman Kovacs; Michael D Cusimano
Journal:  Neurosurgery       Date:  2019-03-01       Impact factor: 4.654

5.  Evaluation of different hydrocortisone treatment strategies in transsphenoidal pituitary surgery.

Authors:  Ola Fridman-Bengtsson; Charlotte Höybye; Laura Porthén; Pär Stjärne; Anna-Lena Hulting; Ola Sunnergren
Journal:  Acta Neurochir (Wien)       Date:  2019-05-07       Impact factor: 2.216

6.  Early postoperative HPA-axis testing after pituitary tumor surgery: reliability and safety of basal cortisol and CRH test.

Authors:  Friso de Vries; Daniel J Lobatto; Leontine E H Bakker; Wouter R van Furth; Nienke R Biermasz; Alberto M Pereira
Journal:  Endocrine       Date:  2019-09-25       Impact factor: 3.633

7.  Diagnostic Accuracy of Perioperative Measurement of Basal Anterior Pituitary and Target Gland Hormones in Predicting Adrenal Insufficiency After Pituitary Surgery.

Authors:  Vatroslav Cerina; Ivan Kruljac; Jelena Marinkovic Radosevic; Lora Stanka Kirigin; Darko Stipic; Hrvoje Ivan Pecina; Milan Vrkljan
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

Review 8.  How should we interrogate the hypothalamic-pituitary-adrenal axis in patients with suspected hypopituitarism?

Authors:  Aoife Garrahy; Amar Agha
Journal:  BMC Endocr Disord       Date:  2016-06-17       Impact factor: 2.763

9.  Lower-dose perioperative steroid protocol during endoscopic endonasal pituitary adenoma resection.

Authors:  Nathan C Pecoraro; Daniel M Heiferman; Brendan Martin; Daphne Li; Stephen J Johans; Chirag R Patel; Anand V Germanwala
Journal:  Surg Neurol Int       Date:  2019-04-24

10.  Postoperative day 1 versus postoperative day 5 morning cortisol for predicting an intact hypothalamic-pituitary axis: A cohort analysis.

Authors:  Esther Dupepe; Daxa Patel; Joseph Miller; Ivania Rizo; Tom Brooks Vaughan; Kristen Riley
Journal:  Surg Neurol Int       Date:  2019-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.